GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Supriya Lifescience Ltd (BOM:543434) » Definitions » EV-to-FCF

Supriya Lifescience (BOM:543434) EV-to-FCF : (As of Jun. 23, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Supriya Lifescience EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Supriya Lifescience's Enterprise Value is ₹31,228 Mil. Supriya Lifescience's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0 Mil. Therefore, Supriya Lifescience's EV-to-FCF for today is .

The historical rank and industry rank for Supriya Lifescience's EV-to-FCF or its related term are showing as below:

BOM:543434' s EV-to-FCF Range Over the Past 10 Years
Min: -96.87   Med: 0   Max: 38.94
Current: -96.54

During the past 6 years, the highest EV-to-FCF of Supriya Lifescience was 38.94. The lowest was -96.87. And the median was 0.00.

BOM:543434's EV-to-FCF is ranked worse than
100% of 402 companies
in the Biotechnology industry
Industry Median: 5.935 vs BOM:543434: -96.54

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-23), Supriya Lifescience's stock price is ₹397.20. Supriya Lifescience's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹14.800. Therefore, Supriya Lifescience's PE Ratio for today is 26.84.


Supriya Lifescience EV-to-FCF Historical Data

The historical data trend for Supriya Lifescience's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Supriya Lifescience EV-to-FCF Chart

Supriya Lifescience Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-FCF
Get a 7-Day Free Trial - - -339.50 -31.66 -80.25

Supriya Lifescience Quarterly Data
Mar19 Mar20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -31.66 - - - -80.25

Competitive Comparison of Supriya Lifescience's EV-to-FCF

For the Biotechnology subindustry, Supriya Lifescience's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Supriya Lifescience's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Supriya Lifescience's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Supriya Lifescience's EV-to-FCF falls into.



Supriya Lifescience EV-to-FCF Calculation

Supriya Lifescience's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=31227.998/0
=

Supriya Lifescience's current Enterprise Value is ₹31,228 Mil.
Supriya Lifescience's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Supriya Lifescience  (BOM:543434) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Supriya Lifescience's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=397.20/14.800
=26.84

Supriya Lifescience's share price for today is ₹397.20.
Supriya Lifescience's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹14.800.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Supriya Lifescience EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Supriya Lifescience's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Supriya Lifescience (BOM:543434) Business Description

Traded in Other Exchanges
Address
Sonawala Road, 207/208, Udyog Bhavan, Goregaon East, Mumbai, MH, IND, 400063
Supriya Lifescience Ltd is a manufacturer of Active pharmaceutical Ingredients. It is focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic.

Supriya Lifescience (BOM:543434) Headlines

No Headlines